SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE197.70-6.4 (-3.14 %)
PREV CLOSE ( ) 204.10
OPEN PRICE ( ) 206.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 69595
TODAY'S LOW / HIGH ( )196.80 206.55
52 WK LOW / HIGH ( )108.2 289
NSE197.98-6.3 (-3.08 %)
PREV CLOSE( ) 204.28
OPEN PRICE ( ) 204.35
BID PRICE (QTY) 197.98 (2245)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 945379
TODAY'S LOW / HIGH( ) 196.57 206.00
52 WK LOW / HIGH ( )108 289
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.